| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 26/09/16 | | 18:02:06 | 26 Sept 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 26/09/16 | | 17:56:19 | 26 Sept 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 23/09/16 | | 14:00:02 | 23 Sept 2016 | | | US Regulatory Submission for sirukumab in RA | GlaxoSmithKline PLC | RNS |
| 20/09/16 | | 08:00:08 | 20 Sept 2016 | | | GSK Appoints New CEO | GlaxoSmithKline PLC | RNS |
| 19/09/16 | | 16:13:16 | 19 Sept 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/09/16 | | 08:00:05 | 15 Sept 2016 | | | Results Phase III Study Shingrix Vaccine in NEJM | GlaxoSmithKline PLC | RNS |
| 12/09/16 | | 17:58:05 | 12 Sept 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/09/16 | | 13:33:39 | 12 Sept 2016 | | | EU regulatory submission for sirukumab in RA | GlaxoSmithKline PLC | RNS |
| 06/09/16 | | 15:49:11 | 6 Sept 2016 | | | Results of Phase III FULFIL Study Presented at ERS | GlaxoSmithKline PLC | RNS |
| 05/09/16 | | 08:00:06 | 5 Sept 2016 | | | Positive Results from the COPD Salford Lung Study | GlaxoSmithKline PLC | RNS |
| 01/09/16 | | 15:42:40 | 1 Sept 2016 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/08/16 | | 13:36:07 | 30 Aug 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 23/08/16 | | 16:45:40 | 23 Aug 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/08/16 | | 16:07:52 | 16 Aug 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/08/16 | | 14:07:20 | 16 Aug 2016 | | | ViiV starts PhIII Programme for dolutegravir & 3TC | GlaxoSmithKline PLC | RNS |
| 12/08/16 | | 17:08:57 | 12 Aug 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/08/16 | | 15:45:38 | 10 Aug 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/08/16 | | 18:43:29 | 9 Aug 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 04/08/16 | | 16:49:34 | 4 Aug 2016 | | | Publication of a Prospectus | GlaxoSmithKline PLC | RNS |
| 01/08/16 | | 16:26:42 | 1 Aug 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/08/16 | | 13:11:10 | 1 Aug 2016 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 01/08/16 | | 08:00:19 | 1 Aug 2016 | | | GSK and Verily to establish Galvani Bioelectronics | GlaxoSmithKline PLC | RNS |
| 28/07/16 | | 19:22:17 | 28 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 27/07/16 | | 13:01:43 | 27 Jul 2016 | | | Half-year Report | GlaxoSmithKline PLC | RNS |
| 25/07/16 | | 16:29:22 | 25 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 18:15:46 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:06 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/07/16 | | 08:00:05 | 20 Jul 2016 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |